Abstract
The etiology of multiple sclerosis (MS) is still not known, but the interaction of genetic, immunological, and environmental factors seem to be involved. This study aimed to investigate genetic alterations and the vitamin D status in patients with relapsing-remitting MS (RRMS) and secondary progressive MS (SPMS). A total of 53 patients (29 RRMS; 24 SPMS) and 25 healthy subjects were recruited to evaluate the micronucleated cell (MNC) frequency and nuclear abnormalities in the buccal mucosa, gene expression profiling in mononuclear cells, and plasmatic vitamin D concentration in the blood. Results showed a higher frequency of cells with karyorrhexis (SPMS) and lower frequencies of nuclear pyknosis (RRMS and SPMS) and karyolysis (SPMS) in patients with MS. Significant increase in the frequency of MNC was detected in the buccal mucosa of RRMS and SPMS patients. HIF1A, IL13, IL18, MYC, and TNF were differentially expressed in MS patients, and APP was overexpressed in cells of RRMS compared to SPMS patients. No relationship was observed between vitamin D level and the differentially expressed genes. In conclusion, the cytogenetic alterations in the buccal mucosa can be important indicators of genetic instability and degenerative processes in patients with MS. Furthermore, our data introduced novel biomarkers associated with the molecular pathogenesis of MS.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Alcalde-Cabero E, Almazán-Isla J, García-Merino A, de Sá J, de Pedro-Cuesta J (2013) Incidence of multiple sclerosis among European Economic Area populations, 1985-2009: the framework for monitoring. BMC Neurol 13:58. https://doi.org/10.1186/1471-2377-13-58
Alharbi FM (2015) Update in vitamin D and multiple sclerosis. Neurosciences 20:329–335. https://doi.org/10.17712/nsj.2015.4.20150357
Baeke F, Takiishi T, Korf H, Gysemans C, Mathieu C (2010) Vitamin D: modulator of the immune system. Curr Opin Pharmacol 10:482–496. https://doi.org/10.1016/j.coph.2010.04.001
Bertazza L, Mocellin S (2010) The dual role of tumor necrosis factor (TNF) in cancer biology. Curr Med Chem 17:3337–3352
Bjørnevik K, Riise T, Casetta I et al (2014) Sun exposure and multiple sclerosis risk in Norway and Italy: the EnvIMS study. Mult Scler Houndmills Basingstoke Engl 20:1042–1049. https://doi.org/10.1177/1352458513513968
Bolognesi C, Knasmueller S, Nersesyan A, Thomas P, Fenech M (2013) The HUMNxl scoring criteria for different cell types and nuclear anomalies in the buccal micronucleus cytome assay - an update and expanded photogallery. Mutat Res 753:100–113. https://doi.org/10.1016/j.mrrev.2013.07.002
Chen Y-C, Chen S-D, Miao L et al (2012) Serum levels of interleukin (IL)-18, IL-23 and IL-17 in Chinese patients with multiple sclerosis. J Neuroimmunol 243:56–60. https://doi.org/10.1016/j.jneuroim.2011.12.008
Christophi GP, Christophi JA, Gruber RC et al (2011) Quantitative differences in the immunomodulatory effects of Rebif and Avonex in IFN-β 1a treated multiple sclerosis patients. J Neurol Sci 307:41–45. https://doi.org/10.1016/j.jns.2011.05.024
Compston A, McDonald I, Noseworthy J et al (2005) McAlpine’s multiple sclerosis, 4th edn. Churchill Livingstone Elsevier, Philadelphia
Coppedè F, Migliore L (2010) DNA repair in premature aging disorders and neurodegeneration. Curr Aging Sci 3:3–19
De Nuccio C, Bernardo A, Cruciani C et al (2015) Peroxisome proliferator activated receptor-γ agonists protect oligodendrocyte progenitors against tumor necrosis factor-alpha-induced damage: effects on mitochondrial functions and differentiation. Exp Neurol 271:506–514. https://doi.org/10.1016/j.expneurol.2015.07.014
Dhillon VS, Thomas P, Fenech M (2004) Comparison of DNA damage and repair following radiation challenge in buccal cells and lymphocytes using single-cell gel electrophoresis. Int J Radiat Biol 80:517–528. https://doi.org/10.1080/09553000410001723866
Ebers GC (2008) Environmental factors and multiple sclerosis. Lancet Neurol 7:268–277. https://doi.org/10.1016/S1474-4422(08)70042-5
Fenech M (2000) The in vitro micronucleus technique. Mutat Res 455:81–95
Fenech M, Chang WP, Kirsch-Volders M, Holland N, Bonassi S, Zeiger E, HUman MicronNucleus project (2003) HUMN project: detailed description of the scoring criteria for the cytokinesis-block micronucleus assay using isolated human lymphocyte cultures. Mutat Res 534:65–75
Fernandes de Abreu DA, Eyles D, Féron F (2009) Vitamin D, a neuro-immunomodulator: implications for neurodegenerative and autoimmune diseases. Psychoneuroendocrinology 34(Suppl 1):S265–S277. https://doi.org/10.1016/j.psyneuen.2009.05.023
Freiesleben S, Hecker M, Zettl UK, Fuellen G, Taher L (2016) Analysis of microRNA and gene expression profiles in multiple sclerosis: integrating interaction data to uncover regulatory mechanisms. Sci Rep 6:34512. https://doi.org/10.1038/srep34512
Gehrmann J, Banati RB, Cuzner ML, Kreutzberg GW, Newcombe J (1995) Amyloid precursor protein (APP) expression in multiple sclerosis lesions. Glia 15:141–151. https://doi.org/10.1002/glia.440150206
Gnanaprakasam JN, Wang R (2017) MYC in regulating immunity: metabolism and beyond. Genes 8:88. https://doi.org/10.3390/genes8030088
Hoel DG, Berwick M, de Gruijl FR, Holick MF (2016) The risks and benefits of sun exposure 2016. Dermatoendocrinol 8:e1248325. https://doi.org/10.1080/19381980.2016.1248325
Huang J, Xie Z-F (2012) Polymorphisms in the vitamin D receptor gene and multiple sclerosis risk: a meta-analysis of case-control studies. J Neurol Sci 313:79–85. https://doi.org/10.1016/j.jns.2011.09.024
Huang W-X, Huang P, Hillert J (2004) Increased expression of caspase-1 and interleukin-18 in peripheral blood mononuclear cells in patients with multiple sclerosis. Mult Scler Houndmills Basingstoke Engl 10:482–487. https://doi.org/10.1191/1352458504ms1071oa
International Multiple Sclerosis Genetics Consortium, Wellcome Trust Case Control Consortium 2, Sawcer S et al (2011) Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis. Nature 476:214–219. https://doi.org/10.1038/nature10251
Islam T, Gauderman WJ, Cozen W, Mack TM (2007) Childhood sun exposure influences risk of multiple sclerosis in monozygotic twins. Neurology 69:381–388. https://doi.org/10.1212/01.wnl.0000268266.50850.48
Jha S, Srivastava SY, Brickey WJ, Iocca H, Toews A, Morrison JP, Chen VS, Gris D, Matsushima GK, Ting JP (2010) The inflammasome sensor, NLRP3, regulates CNS inflammation and demyelination via caspase-1 and interleukin-18. J Neurosci Off J Soc Neurosci 30:15811–15820. https://doi.org/10.1523/JNEUROSCI.4088-10.2010
Jorde R (2018) RCTS are the only appropriate way to demonstrate the role of vitamin D in health. J Steroid Biochem Mol Biol 177:10–14. https://doi.org/10.1016/j.jsbmb.2017.05.004
Kingwell E, Marriott JJ, Jetté N, Pringsheim T, Makhani N, Morrow SA, Fisk JD, Evans C, Béland SG, Kulaga S, Dykeman J, Wolfson C, Koch MW, Marrie RA (2013) Incidence and prevalence of multiple sclerosis in Europe: a systematic review. BMC Neurol 13:128. https://doi.org/10.1186/1471-2377-13-128
Kodama S, Davis M, Faustman DL (2005) The therapeutic potential of tumor necrosis factor for autoimmune disease: a mechanistically based hypothesis. Cell Mol Life Sci CMLS 62:1850–1862. https://doi.org/10.1007/s00018-005-5022-6
Kulkarni A, Wilson DM (2008) The involvement of DNA-damage and -repair defects in neurological dysfunction. Am J Hum Genet 82:539–566. https://doi.org/10.1016/j.ajhg.2008.01.009
Le Moan N, Baeten KM, Rafalski VA et al (2015) Hypoxia inducible factor-1αin astrocytes and/or myeloid cells is not required for the development of autoimmune demyelinating disease. eNeuro 2. https://doi.org/10.1523/ENEURO.0050-14.2015
Losy J, Niezgoda A (2001) IL-18 in patients with multiple sclerosis. Acta Neurol Scand 104:171–173. https://doi.org/10.1034/j.1600-0404.2001.00356.x
Lublin FD, Reingold SC (1996) Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis. Neurology 46:907–9113
Lublin FD, Reingold SC, Cohen JA et al (2014) Defining the clinical course of multiple sclerosis: the 2013 revisions. Neurology 83:278–286. https://doi.org/10.1212/WNL.0000000000000560
Lund BT, Ashikian N, Ta HQ et al (2004) Increased CXCL8 (IL-8) expression in multiple sclerosis. J Neuroimmunol 155:161–171. https://doi.org/10.1016/j.jneuroim.2004.06.008
Mansouri B, Asadollahi S, Heidari K et al (2014) Risk factors for increased multiple sclerosis susceptibility in the Iranian population. J Clin Neurosci Off J Neurosurg Soc Australas 21:2207–2211. https://doi.org/10.1016/j.jocn.2014.04.020
Marcus JF, Waubant EL (2013) Updates on clinically isolated syndrome and diagnostic criteria for multiple sclerosis. The Neurohospitalist 3:65–80. https://doi.org/10.1177/1941874412457183
Marik C, Felts PA, Bauer J, Lassmann H, Smith KJ (2007) Lesion genesis in a subset of patients with multiple sclerosis: a role for innate immunity? Brain J Neurol 130:2800–2815. https://doi.org/10.1093/brain/awm236
Matías-Guiu JA, Oreja-Guevara C, Cabrera-Martín MN et al (2016) Amyloid proteins and their role in multiple sclerosis. Considerations in the use of amyloid-PET Imaging. Front Neurol 7. https://doi.org/10.3389/fneur.2016.00053
Migliore L, Coppedè F, Fenech M, Thomas P (2011) Association of micronucleus frequency with neurodegenerative diseases. Mutagenesis 26:85–92. https://doi.org/10.1093/mutage/geq067
Milenkova M, Milanov I, Kmetska K, Deleva S, Popova L, Hadjidekova V, Groudeva V, Hadjidekova S, Domínguez I (2013) Chromosomal radiosensitivity in patients with multiple sclerosis. Mutat Res 749:3–8. https://doi.org/10.1016/j.mrfmmm.2013.08.004
Minicucci EM, Ribeiro DA, de Camargo B, Costa MC, Ribeiro LR, Favero Salvadori DM (2008) DNA damage in lymphocytes and buccal mucosa cells of children with malignant tumours undergoing chemotherapy. Clin Exp Med 8:79–85. https://doi.org/10.1007/s10238-008-0161-3
Montgomery SL, Bowers WJ (2012) Tumor necrosis factor-alpha and the roles it plays in homeostatic and degenerative processes within the central nervous system. J Neuroimmune Pharmacol Off J Soc NeuroImmune Pharmacol 7:42–59. https://doi.org/10.1007/s11481-011-9287-2
MSIF (2013) Multiple Sclerosis International Federation. Atlas of MS in 2013. Mapping multiple sclerosis around the world. Modern Colour Solutions
Muñoz-Culla M, Irizar H, Otaegui D (2013) The genetics of multiple sclerosis: review of current and emerging candidates. Appl Clin Genet 6:63–73. https://doi.org/10.2147/TACG.S29107
Musabak U, Demirkaya S, Genç G, Ilikci RS, Odabasi Z (2011) Serum adiponectin, TNF-α, IL-12p70, and IL-13 levels in multiple sclerosis and the effects of different therapy regimens. Neuroimmunomodulation 18:57–66. https://doi.org/10.1159/000317393
Naghavi Gargari B, Behmanesh M, Shirvani Farsani Z, Pahlevan Kakhki M, Azimi AR (2015) Vitamin D supplementation up-regulates IL-6 and IL-17A gene expression in multiple sclerosis patients. Int Immunopharmacol 28:414–419. https://doi.org/10.1016/j.intimp.2015.06.033
Nejati A, Shoja Z, Shahmahmoodi S, Tafakhori A, Mollaei-Kandelous Y, Rezaei F, Hamid KM, Mirshafiey A, Doosti R, Sahraian MA, Mahmoudi M, Shokri F, Emery V, Marashi SM (2016) EBV and vitamin D status in relapsing-remitting multiple sclerosis patients with a unique cytokine signature. Med Microbiol Immunol (Berl) 205:143–154. https://doi.org/10.1007/s00430-015-0437-7
Parnell GP, Booth DR (2017) The multiple sclerosis (MS) genetic risk factors indicate both acquired and innate immune cell subsets contribute to MS pathogenesis and identify novel therapeutic opportunities. Front Immunol 8:425. https://doi.org/10.3389/fimmu.2017.00425
Peiravian F, Rajaian H, Samiei A et al (2016) Altered serum cytokine profiles in relapse phase of relapsing-remitting multiple sclerosis. Iran J Immunol IJI 13:186–196 IJIv13i3A4
Pierrot-Deseilligny C (2009) Clinical implications of a possible role of vitamin D in multiple sclerosis. J Neurol 256:1468–1479. https://doi.org/10.1007/s00415-009-5139-x
Pietroboni AM, di Cola FS, Scarioni M et al (2017) CSF β-amyloid as a putative biomarker of disease progression in multiple sclerosis. Multiple Sclerosis J 23:1085–1091. https://doi.org/10.1177/1352458516674566
Pike JW, Meyer MB (2012) The vitamin D receptor: new paradigms for the regulation of gene expression by 1,25-dihydroxyvitamin D3. Rheum Dis Clin North Am 38:13–27. https://doi.org/10.1016/j.rdc.2012.03.004
Polman CH, Reingold SC, Banwell B, Clanet M, Cohen JA, Filippi M, Fujihara K, Havrdova E, Hutchinson M, Kappos L, Lublin FD, Montalban X, O'Connor P, Sandberg-Wollheim M, Thompson AJ, Waubant E, Weinshenker B, Wolinsky JS (2011) Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol 69:292–302. https://doi.org/10.1002/ana.22366
Prietl B, Treiber G, Pieber TR, Amrein K (2013) Vitamin D and immune function. Nutrients 5:2502–2521. https://doi.org/10.3390/nu5072502
Ross CA, Truant R (2017) DNA repair: a unifying mechanism in neurodegeneration. Nature 541:34–35. https://doi.org/10.1038/nature21107
Rossi S, Motta C, Studer V et al (2014) Tumor necrosis factor is elevated in progressive multiple sclerosis and causes excitotoxic neurodegeneration. Mult Scler Houndmills Basingstoke Engl 20:304–312. https://doi.org/10.1177/1352458513498128
Sadeghi H, Taheri M, Sajjadi E et al (2017) VDR and CYP24A1 expression analysis in Iranian relapsing-remitting multiple sclerosis patients. Cell J Yakhteh:352–360. https://doi.org/10.22074/cellj.2017.4192
Scalfari A, Neuhaus A, Daumer M et al (2014) Onset of secondary progressive phase and long-term evolution of multiple sclerosis. J Neurol Neurosurg Psychiatry 85:67–75. https://doi.org/10.1136/jnnp-2012-304333
Shackelford DA (2006) DNA end joining activity is reduced in Alzheimer’s disease. Neurobiol Aging 27:596–605. https://doi.org/10.1016/j.neurobiolaging.2005.03.009
Simpson S, Taylor B, Blizzard L et al (2010) Higher 25-hydroxyvitamin D is associated with lower relapse risk in multiple sclerosis. Ann Neurol 68:193–203. https://doi.org/10.1002/ana.22043
Smolders J, Thewissen M, Theunissen R, Peelen E, Knippenberg S, Menheere P, Cohen Tervaert JW, Hupperts R, Damoiseaux J (2011) Vitamin D-related gene expression profiles in immune cells of patients with relapsing remitting multiple sclerosis. J Neuroimmunol 235:91–97. https://doi.org/10.1016/j.jneuroim.2011.03.012
Souberbielle J-C, Body J-J, Lappe JM, Plebani M, Shoenfeld Y, Wang TJ, Bischoff-Ferrari HA, Cavalier E, Ebeling PR, Fardellone P, Gandini S, Gruson D, Guérin AP, Heickendorff L, Hollis BW, Ish-Shalom S, Jean G, von Landenberg P, Largura A, Olsson T, Pierrot-Deseilligny C, Pilz S, Tincani A, Valcour A, Zittermann A (2010) Vitamin D and musculoskeletal health, cardiovascular disease, autoimmunity and cancer: recommendations for clinical practice. Autoimmun Rev 9:709–715. https://doi.org/10.1016/j.autrev.2010.06.009
Stadelmann C, Ludwin S, Tabira T, Guseo A, Lucchinetti CF, Leel-Ossy L, Ordinario AT, Brück W, Lassmann H (2005) Tissue preconditioning may explain concentric lesions in Baló’s type of multiple sclerosis. Brain J Neurol 128:979–987. https://doi.org/10.1093/brain/awh457
Stampanoni MB, Mori F, Buttari F et al (2017) Neurophysiology of synaptic functioning in multiple sclerosis. Clin Neurophysiol Off J Int Fed Clin Neurophysiol 128:1148–1157. https://doi.org/10.1016/j.clinph.2017.04.006
Swardfager W, Lanctôt K, Rothenburg L et al (2010) A meta-analysis of cytokines in Alzheimer’s disease. Biol Psychiatry 68:930–941. https://doi.org/10.1016/j.biopsych.2010.06.012
Thomas P, Hecker J, Faunt J, Fenech M (2007) Buccal micronucleus cytome biomarkers may be associated with Alzheimer’s disease. Mutagenesis 22:371–379. https://doi.org/10.1093/mutage/gem029
Thomas P, Holland N, Bolognesi C et al (2009) Buccal micronucleus cytome assay. Nat Protoc 4:825–837. https://doi.org/10.1038/nprot.2009.53
Weissman L, Jo D-G, Sørensen MM, de Souza-Pinto NC, Markesbery WR, Mattson MP, Bohr VA (2007) Defective DNA base excision repair in brain from individuals with Alzheimer’s disease and amnestic mild cognitive impairment. Nucleic Acids Res 35:5545–5555. https://doi.org/10.1093/nar/gkm605
Yang Q, Pan W, Qian L (2017) Identification of the miRNA–mRNA regulatory network in multiple sclerosis. Neurol Res 39:142–151. https://doi.org/10.1080/01616412.2016.1250857
Yildiz M, Tettenborn B, Putzki N (2011) Vitamin D levels in Swiss multiple sclerosis patients. Swiss Med Wkly 141:w13192. https://doi.org/10.4414/smw.2011.13192
Zeis T, Graumann U, Reynolds R, Schaeren-Wiemers N (2008) Normal-appearing white matter in multiple sclerosis is in a subtle balance between inflammation and neuroprotection. Brain J Neurol 131:288–303. https://doi.org/10.1093/brain/awm291
Acknowledgments
The authors are grateful to Brenda Anfilo for technical assistance and to Dr. Fábio H. Fernandes for the scientific illustration.
Funding
This study was supported by the National Council for Scientific and Technological Development (CNPq-471312/2012-6)—Brazil.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Ethics Statement
The Ethics Committee on Human Research of the Faculty of Medicine of Botucatu, (FMB)-UNESP approved the study protocol (CEP-4072-2011).
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Feliciano, L.M., Sávio, A.L.V., de Castro Marcondes, J.P. et al. Genetic Alterations in Patients with Two Clinical Phenotypes of Multiple Sclerosis. J Mol Neurosci 70, 120–130 (2020). https://doi.org/10.1007/s12031-019-01408-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12031-019-01408-7